|
|
Article: NeoGenomics Reports Third Quarter 2009 Results.
- Article from:
- PR Newswire
- Article date:
- October 29, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
FT. MYERS, Fla., Oct. 29 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM), a leading provider of cancer-focused genetic testing services today reported its results for the third quarter of 2009.
Highlights:
-- Revenue increase of 44% versus Q3 08 to $7.3 million
-- Build-out of a full-service melanoma laboratory and commencement of a
large melanoma validation study
-- Significantly improved liquidity position
-- Douglas VanOort appointed Chief Executive Officer
Revenue increased by $2.2 million or 44% to $7.3 million in the third quarter from $5.1 million in the same quarter last year. The number of ...